Viral replication and development of specific immunity in macaques after infection with different measles virus strains

Journal of Infectious Diseases

Volumn 170, Issue 2, 1994, Pages 443-448

  Van Binnendijk, Robert S ^a,b   Van der Heijden, Roger W J ^a,b   Amerongen, Geert Van ^a,b   Uytdehaag, Fons G C M ^a,b   Osterhaus, Albert D M E ^a,b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MEASLES VACCINE; NEUTRALIZING ANTIBODY; NUCLEOTIDE;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MACACA; MEASLES VACCINATION; MEASLES VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIREMIA; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ANIMAL; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; HUMAN; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KINETICS; LEUKOCYTES, MONONUCLEAR; LUNG; MACACA FASCICULARIS; MEASLES; MEASLES VIRUS; PHARYNX; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; VIREMIA; VIRUS REPLICATION;

EID: 0028284446     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/170.2.443     Document Type: Article

References (16)

1. Norrby E. Measles vaccination, today and tomorrow. Ann Inst Pasteur/Virol 1985; 136E:561-70.
2. UytdeHaag FGCM, van Binnendijk RS, Renter MJH, Osterhaus ADME. Cytotoxic T lymphocyte responses against measles virus. CurrTop Microbiol Immunol 1994;189:151-67.
3. Gustafson TL, Lievens AW, Brunnel PA, Moellenberg RG, Buttery
4. CMG, Sehulster LM, Measles outbreak in a fully immunized second-ary-school population. N Engl J Med 1987;316:771-4.
5. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: Réévaluation of protective titers. J Infect Dis 1990;162:1036-42.
6. Markowitz LE, Preblud S R, Orenstein WA, et al. Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med 1989:320:75-81.
7. Weiss R. Measles battle loses potent weapon. Science 1992;258:546-7.
8. Expanded Programme on Immunization. Measles control in the 1990s: Plan of action for global measles control. Geneva: World Health Organization, 1992:WHO/EPl/Gen/92.3.
9. van Binnendijk RS, van der Heijden RWJ, Osterhaus ADME. Mon keys in measles research. Curr Top Microbiol Immunol 1994 (in press).
10. Albrecht P, Lorenz D, Klutch MJ, Vicjers JH, Ennis FA. Fatal measles infection in marmoset pathogenesis and prophylaxis. Infect Immun 1980;27:969-78.
11. van Binnendijk RS, Riimke H C, Van Eijndhoven M J, et al. A measles outbreak in vaccinated schoolaged children in the Netherlands: Identification of clinically and subclinically infected children by evaluation of virus-specific antibody and T cell responses. In: T cell function in measles [doctoral thesis]. Chapter 2. Utrecht, Netherlands: University of Utrecht, 1992.
12. van Binnendijk RS, Versteeg-van Oosten J P M, Poelen MCM, et al. Human HLA class 1- and 11—restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein. J Virol 1993;67:2276-84.
13. De Vries P, van Binnendijk RS, van der Marel P, et al. Measles virus fusion protein presented in immune-stimulating complex (ISCOM) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. J Gen Virol 1988;69:549-59.
14. Taylor MJ, Godfrey E, Baczko K, ter Meulen V, Wild TF, Rima BK. Identification of several lineages of measles virus. J Gen Virol 1992;72:83-8.
15. Kobune F, Skata H, Sugiura A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol 1990;64:700-5.
16. Enders JF, Katz SL, Milovanovic MV, Holloway A. Studies on an attenuated measles-virus vaccine. 1. Development and preparation of the vaccine: Techniques for assay of effects of vaccination. N Engl J Med 1960;263:153-9.